The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Oxidative and nitrative stress in neurodegeneration
Open accessAbstract
Aerobes require oxygen for metabolism and normal free radical formation. As a result, maintaining the redox homeostasis is essential for brain cell survival due to their high metabolic energy requirement to sustain electrochemical gradients, neurotransmitter release, and membrane lipid stability. Further, brain antioxidant levels are limited compared to other organs and less able to compensate for reactive oxygen and nitrogen species (ROS/RNS) generation which contribute oxidative/nitrative stress (OS/NS). Antioxidant treatments such as vitamin E, minocycline, and resveratrol mediate neuroprotection by prolonging the incidence of or reversing OS and NS conditions. Redox imbalance occurs when the antioxidant capacity is overwhelmed, consequently leading to activation of alternate pathways that remain quiescent under normal conditions. If OS/NS fails to lead to adaptation, tissue damage and injury ensue, resulting in cell death and/or disease. The progression of OS/NS-mediated neurodegeneration along with contributions from microglial activation, dopamine metabolism, and diabetes comprise a detailed interconnected pathway. This review proposes a significant role for OS/NS and more specifically, lipid peroxidation (LPO) and other lipid modifications, by triggering microglial activation to elicit a neuroinflammatory state potentiated by diabetes or abnormal dopamine metabolism. Subsequently, sustained stress in the neuroinflammatory state overwhelms cellular defenses and prompts neurotoxicity resulting in the onset or amplification of brain damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/360438 · Cited by 6,349
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 15×
“Decreased quantities of choline causes diminished ACh synthesis in the presence of OS.”
InfluentialAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Toxicity of iron and hydrogen peroxide: the Fenton reaction
Winterbourn, C. C. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03532-x · Cited by 1,415
Craft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 1×
“Minocycline treatment yields attenuation of both DA loss and 3-NT modifications in ischemia (Yrjanheikki et al., 1998) and has provided neuroprotection in AD (Biscaro et al., 2012), MS (Brundula et al., 2002), HD (Ryu et al., 2006), and PD (Du et al., 2001, Wu et al., 2002).”
Microglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Löscher, W. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.003 · Cited by 932
S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Uehara, T., Nakamura, T., Yao, D., Shi, Z.-Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., & Lipton, S. A. (2006) · Nature · doi:10.1038/nature04782 · Cited by 906
Peroxynitrite, a Stealthy Biological Oxidant
Radi, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.472936 · Cited by 888
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal
Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 802
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
S -Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function
Chung, K. K. K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J. C., Marsh, L., Dawson, V. L., & Dawson, T. M. (2004) · Science · doi:10.1126/science.1093891 · Cited by 769
Oxidative damage in multiple sclerosis lesions
Haider, L., Fischer, M. T., Frischer, J. M., Bauer, J., Hoftberger, R., Botond, G., Esterbauer, H., Binder, C. J., Witztum, J. L., & Lassmann, H. (2011) · Brain · doi:10.1093/brain/awr128 · Cited by 753
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Bal-Price, A., & Brown, G. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06480.2001 · Cited by 686
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673
Normal huntingtin function: an alternative approach to Huntington's disease
Cattaneo, E., Zuccato, C., & Tartari, M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1806 · Cited by 657
Nitric oxide, cell bioenergetics and neurodegeneration
Moncada, S., & Bolaños, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03988.x · Cited by 556
The role of nitric oxide in multiple sclerosis
Smith, K. J., & Lassmann, H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00102-3 · Cited by 531
Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons
Brown, G. C., & Neher, J. J. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8105-9 · Cited by 528
Protein Tyrosine Nitration: Biochemical Mechanisms and Structural Basis of Functional Effects
Radi, R. (2013) · Accounts of Chemical Research · doi:10.1021/ar300234c · Cited by 525
Poly (ADP-ribose) polymerase, nitric oxide and cell death
Pieper, A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01292-4 · Cited by 517
Oxidative stress in Huntington’s disease
Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508
Sultana, R., Perluigi, M., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.027 · Cited by 478
Endogenous production of hydrogen sulfide in mammals
Kamoun, P. (2004) · Amino Acids · doi:10.1007/s00726-004-0072-x · Cited by 445
Targeting leukocyte MMPs and transmigration
Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C., & Yong, V. W. (2002) · Brain · doi:10.1093/brain/awf133 · Cited by 426
Glaucoma as a neurodegenerative disease
Gupta, N., & Yücel, Y. H. (2007) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3280895aea · Cited by 422
Ara, J., Przedborski, S., Naini, A. B., Jackson-Lewis, V., Trifiletti, R. R., Horwitz, J., & Ischiropoulos, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7659 · Cited by 414
Microglial Activation in Stroke: Therapeutic Targets
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.005 · Cited by 389
Complex Inhibitory Effects of Nitric Oxide on Autophagy
Sarkar, S., Korolchuk, V. I., Renna, M., Imarisio, S., Fleming, A., Williams, A., Garcia-Arencibia, M., Rose, C., Luo, S., Underwood, B. R., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.029 · Cited by 383
Nitric oxide and lipid peroxidation
Hogg, N., & Kalyanaraman, B. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00027-4 · Cited by 380
Vinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.001 · Cited by 366
Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models
Hu, L., Lu, M., Tiong, C. X., Dawe, G. S., Hu, G., & Bian, J. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00543.x · Cited by 365
Haider, L., Simeonidou, C., Steinberger, G., Hametner, S., Grigoriadis, N., Deretzi, G., Kovacs, G. G., Kutzelnigg, A., Lassmann, H., & Frischer, J. M. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307712 · Cited by 357
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
Stoy, N., Mackay, G. M., Forrest, C. M., Christofides, J., Egerton, M., Stone, T. W., & Darlington, L. G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03070.x · Cited by 310
The relevance of animal models in multiple sclerosis research
Denic, A., Johnson, A. J., Bieber, A. J., Warrington, A. E., Rodriguez, M., & Pirko, I. (2011) · Pathophysiology · doi:10.1016/j.pathophys.2010.04.004 · Cited by 298
O'Donnell, V. B., Eiserich, J. P., Chumley, P. H., Jablonsky, M. J., Krishna, N. R., Kirk, M., Barnes, S., Darley-Usmar, V. M., & Freeman, B. A. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980207u · Cited by 289
Tabet, N. (2006) · Age and Ageing · doi:10.1093/ageing/afl027 · Cited by 285
Khan, M. M., Ahmad, A., Ishrat, T., Khan, M. B., Hoda, M. N., Khuwaja, G., Raza, S. S., Khan, A., Javed, H., Vaibhav, K., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.031 · Cited by 279
The role of lipid peroxidation in neurological disorders
Shichiri, M. (2014) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.14-10 · Cited by 269
Nitro-fatty acid formation and signaling
Freeman, B. A., Baker, P. R. S., Schopfer, F. J., Woodcock, S. R., Napolitano, A., & d'Ischia, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800004200 · Cited by 265
Neuroinflammation, Neurodegeneration, and Depression
Hurley, L. L., & Tizabi, Y. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9348-1 · Cited by 259
Neuroprotective effects of resveratrol in Alzheimer disease pathology
Rege, S. D., Geetha, T., Griffin, G. D., Broderick, T. L., & Babu, J. R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00218 · Cited by 243
Dopamine and noradrenaline control distinct functions in rodent microglial cells
Färber, K., Pannasch, U., & Kettenmann, H. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.01.003 · Cited by 238
Chen, C.-M., Wu, Y.-R., Cheng, M.-L., Liu, J.-L., Lee, Y.-M., Lee, P.-W., Soong, B.-W., & Chiu, D. T.-Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.093 · Cited by 228
The benefits and detriments of macrophages/microglia in models of multiple sclerosis
Rawji, K. S., & Yong, V. W. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/948976 · Cited by 217 · cited 1×
“Although microglial function in the healthy or unaffected nervous system is largely unknown, their function in diseased conditions can be beneficial or harmful, suggesting complex mechanisms are at play (Yenari et al., 2010, Tan et al., 2012, Rawji and Yong, 2013).”
Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress
Ganfornina, M. D., Do Carmo, S., Lora, J. M., Torres‐Schumann, S., Vogel, M., Allhorn, M., González, C., Bastiani, M. J., Rassart, E., & Sanchez, D. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00395.x · Cited by 216
Up-regulation of Microglial CD11b Expression by Nitric Oxide
Roy, A., Fung, Y. K., Liu, X., & Pahan, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600236200 · Cited by 214
Sandhir, R., Yadav, A., Mehrotra, A., Sunkaria, A., Singh, A., & Sharma, S. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8261-y · Cited by 204
Transduction of Redox Signaling by Electrophile-Protein Reactions
Rudolph, T. K., & Freeman, B. A. (2009) · Science Signaling · doi:10.1126/scisignal.290re7 · Cited by 202
Nitro-fatty Acid Reaction with Glutathione and Cysteine
Baker, L. M. S., Baker, P. R. S., Golin-Bisello, F., Schopfer, F. J., Fink, M., Woodcock, S. R., Branchaud, B. P., Radi, R., & Freeman, B. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704085200 · Cited by 200
Pangeni, R., Sharma, S., Mustafa, G., Ali, J., & Baboota, S. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/48/485102 · Cited by 192
Zhang, F., Shi, J.-S., Zhou, H., Wilson, B., Hong, J.-S., & Gao, H.-M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064535 · Cited by 190
Blöchl, A., & Sirrenberg, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21100 · Cited by 182
Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Koylu, E., & Yalcin, A. (2014) · Free Radical Research · doi:10.3109/10715762.2013.857018 · Cited by 169 · cited 2×
“It is also possible that activated PARP1 functions downstream of Aβ in AD to signal within a pathway that engenders OS and cell death in the brain (Turunc Bayrakdar et al., 2014).”
Greilberger, J., Koidl, C., Greilberger, M., Lamprecht, M., Schroecksnadel, K., Leblhuber, F., Fuchs, D., & Oettl, K. (2008) · Free Radical Research · doi:10.1080/10715760802255764 · Cited by 167
Biscaro, B., Lindvall, O., Tesco, G., Ekdahl, C. T., & Nitsch, R. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000330363 · Cited by 164
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain
Dassati, S., Waldner, A., & Schweigreiter, R. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.148 · Cited by 163
Duarte, A. I., Candeias, E., Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Plácido, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.008 · Cited by 162
Nitration of Hsp90 induces cell death
Franco, M. C., Ye, Y., Refakis, C. A., Feldman, J. L., Stokes, A. L., Basso, M., de Mera, R. M. M.-F., Sparrow, N. A., Calingasan, N. Y., Kiaei, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215177110 · Cited by 160
Ali, T. K., Matragoon, S., Pillai, B. A., Liou, G. I., & El-Remessy, A. B. (2008) · Diabetes · doi:10.2337/db07-1669 · Cited by 158
S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease
Tsang, A. H. K., Lee, Y.-I., Ko, H. S., Savitt, J. M., Pletniková, O., Troncoso, J. C., Dawson, V. L., Dawson, T. M., & Chung, K. K. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810595106 · Cited by 154
Lofrumento, D., Nicolardi, G., Cianciulli, A., Nuccio, F. D., Pesa, V. L., Carofiglio, V., Dragone, T., Calvello, R., & Panaro, M. (2014) · Innate Immunity · doi:10.1177/1753425913488429 · Cited by 153
Conjugated linoleic acid is a preferential substrate for fatty acid nitration
Bonacci, G., Baker, P. R. S., Salvatore, S. R., Shores, D., Khoo, N. K. H., Koenitzer, J. R., Vitturi, D. A., Woodcock, S. R., Golin-Bisello, F., Cole, M. P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401356 · Cited by 147 · cited 3×
“It has recently been determined that conjugated linoleic acid is the favored target for fatty acid nitration in vivo (Bonacci et al., 2012).”
InfluentialSelf-citationCai, Z., Lin, S., Fan, L.-W., Pang, Y., & Rhodes, P. G. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.023 · Cited by 146
Ting, J. T., Kelley, B. G., Lambert, T. J., Cook, D. G., & Sullivan, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608807104 · Cited by 140
Protein and lipid nitration: Role in redox signaling and injury
Rubbo, H., & Radí, R. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.03.007 · Cited by 140
Inman, D. M., Lambert, W. S., Calkins, D. J., & Horner, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065389 · Cited by 138
Quincozes‐Santos, A., Bobermin, L. D., Latini, A., Wajner, M., Souza, D. O., Gonçalves, C., & Gottfried, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064372 · Cited by 137
Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo
Kim, H. G., Moon, M., Choi, J. G., Park, G., Kim, A., Hur, J., Lee, K., & Oh, M. S. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.10.004 · Cited by 137
Hypoinsulinemia Regulates Amphetamine-Induced Reverse Transport of Dopamine
Williams, J. M., Owens, W. A., Turner, G. H., Saunders, C., Dipace, C., Blakely, R., France, C. P., Gore, J. C., Daws, L. C., Avison, M. J., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050274 · Cited by 136
Thomas, D. M., Francescutti, D. M., & Kuhn, D. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05155.x · Cited by 133
Pong, K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.127 · Cited by 131
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis
Rejdak, K., Eikelenboom, M. J., Petzold, A., Thompson, E. J., Stelmasiak, Z., Lazeron, R. H. C., Barkhof, F., Polman, C. H., Uitdehaag, B. M. J., & Giovannoni, G. (2004) · Neurology · doi:10.1212/01.wnl.0000142043.32578.5d · Cited by 129
Inhibitors of Microglial Neurotoxicity: Focus on Natural Products
Choi, D., Koppula, S., & Suk, K. (2011) · Molecules · doi:10.3390/molecules16021021 · Cited by 128
Silva‐Adaya, D., Cruz, V. P. L., Herrera‐Mundo, M. N., Mendoza‐Macedo, K., Villeda‐Hernández, J., BINIENDA, Z. K., Ali, S. F., & Santamaría, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05174.x · Cited by 125
Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine Release
Zhang, L., Zhou, F.-M., & Dani, J. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000299 · Cited by 122
Szutowicz, A., Bielarczyk, H., Jankowska-Kulawy, A., Pawełczyk, T., & Ronowska, A. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1060-x · Cited by 120
Kokaia, Z., Andsberg, G., Martínez-Serrano, A., & Lindvall, O. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00579-4 · Cited by 116
Olives and olive oil are sources of electrophilic fatty acid nitroalkenes
Fazzari, M., Trostchansky, A., Schopfer, F. J., Salvatore, S. R., Sánchez-Calvo, B., Vitturi, D., Valderrama, R., Barroso, J. B., Radi, R., Freeman, B. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084884 · Cited by 114
Dopamine Quinones Activate Microglia and Induce a Neurotoxic Gene Expression Profile
Kuhn, D. M., Francescutti, D. M., & Thomas, D. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.003 · Cited by 114
Regulation of autophagy by lysosomal positioning
Korolchuk, V. I., & Rubinsztein, D. C. (2011) · Autophagy · doi:10.4161/auto.7.8.15862 · Cited by 113
Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid β
Kauppinen, T. M., Suh, S., Higashi, Y., Berman, A. E., Escartin, C., Won, S., Wang, C., Cho, S.-H., Gan, L., & Swanson, R. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-152 · Cited by 112 · cited 1×
“Inhibition of PARP1 has also been shown to prevent Aβ-dependent MGLA, which in turn prevents neurotoxicity from ROS produced as a result of MGLA (Pieper et al., 1999, Kauppinen et al., 2011).”
Poly(ADP-ribose) Polymerase-1 in Amyloid Beta Toxicity and Alzheimer's Disease
Strosznajder, J. B., Czapski, G. A., Adamczyk, A., & Strosznajder, R. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8258-9 · Cited by 110
Skundric, D. S., & Lisak, R. P. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.303 · Cited by 110
Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain
Strauss, K. I. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.09.011 · Cited by 109
Neurodegeneration in Diabetes Mellitus
Umegaki, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_19 · Cited by 109
Inflammation: Therapeutic Targets for Diabetic Neuropathy
Zhou, J., & Zhou, S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8537-0 · Cited by 107
Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues
Crabb, J. W., O'NEIL, J. A., Miyagi, M., West, K. A., & Hoff, H. F. (2002) · Protein Science · doi:10.1110/ps.4400102 · Cited by 105
Shin, E., Ko, K. H., Kim, W.-K., Chae, J. S., Yen, T. P. H., Kim, H. J., Wie, M., & Kim, H. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.12.003 · Cited by 102
Genetic Mouse Models of Huntington’s Disease: Focus on Electrophysiological Mechanisms
Cepeda, C., Cummings, D. M., André, V., Holley, S. M., & Levine, M. S. (2010) · ASN NEURO · doi:10.1042/an20090058 · Cited by 101
Turner, B. J., Cheah, I. K.-M., Macfarlane, K. J., Lopes, E. C., Petratos, S., Langford, S. J., & Cheema, S. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02053.x · Cited by 100
Jing, Y., Chen, K., Kuo, P., Pao, C.-C., & Chen, J. (2013) · Neuroendocrinology · doi:10.1159/000350435 · Cited by 97
Wong, E. S. P., Tan, J. M. M., Wang, C., Zhang, Z., Tay, S.-P., Zaiden, N., Ko, H. S., Dawson, V. L., Dawson, T. M., & Lim, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609466200 · Cited by 92
López‐Sánchez, C., Martín-Romero, F. J., Sun, F., Luis, L. G., Samhan-Arias, A. K., García‐Martínez, V., & Gutiérrez‐Merino, C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.087 · Cited by 90
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
Bisaglia, M., Filograna, R., Beltramini, M., & Bubacco, L. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.009 · Cited by 88
Vareniuk, І., Pavlov, I. A., & Obrosova, I. G. (2008) · Diabetologia · doi:10.1007/s00125-008-1136-3 · Cited by 88
Methamphetamine and Parkinson's Disease
Granado, N., Ares‐Santos, S., & Moratalla, R. (2013) · Parkinson s Disease · doi:10.1155/2013/308052 · Cited by 88
Chung, E. S., Chung, Y. C., Bok, E., Baik, H. H., Park, E. S., Park, J., Yoon, S., & Jin, B. K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.049 · Cited by 86
Shchepinov, M. S., Chou, V., Pollock, E. D., Langston, J. W., Cantor, C. R., Molinari, R. J., & Manning-Bog, A. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.07.020 · Cited by 82
Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Pallàs, M., Porquet, D., Vicente, A., & Sanfeliu, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319380005 · Cited by 81
Belluzzi, E., Bisaglia, M., Lazzarini, E., Tabares, L. C., Beltramini, M., & Bubacco, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038026 · Cited by 81
Thomas, D. M., Francescutti, D. M., & Kuhn, D. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4873fje · Cited by 80
Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy
Stavniichuk, R., Shevalye, H., Lupachyk, S., Obrosov, A. A., Groves, J. T., Obrosova, I. G., & Yorek, M. A. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2549 · Cited by 79
Ryu, J. K., Choi, H. B., & McLarnon, J. G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.043 · Cited by 78
Kraemer, B. R., Snow, J. P., Vollbrecht, P. J., Pathak, A., Valentine, W. M., Deutch, A. Y., & Carter, B. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.563403 · Cited by 77
Rejdak, K., Petzold, A., Stelmasiak, Z., & Giovannoni, G. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507082061 · Cited by 71
Villani, G. R. D., Domenico, C. D., Musella, A., Cecere, F., Napoli, D. D., & Natale, P. D. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.071 · Cited by 68
Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice
Vareniuk, І., Pavlov, I. A., Drel, V. R., Lyzogubov, V. V., Ilnytska, O., Bell, S. R., Tibrewala, J., Groves, J. T., & Obrosova, I. G. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.019 · Cited by 67
Prostate cancer and physical activity: Adaptive response to oxidative stress
Rébillard, A., Lefeuvre‐Orfila, L., Guéritat, J., & Cillard, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.009 · Cited by 64
Autophagy, reactive oxygen species and the fate of mammalian cells
Szumiel, I. (2010) · Free Radical Research · doi:10.3109/10715762.2010.525233 · Cited by 64
Resveratrol Protects the Brain of Obese Mice from Oxidative Damage
Rege, S. D., Kumar, S., Wilson, D. N., Tamura, L. K., Geetha, T., Mathews, S. T., Huggins, K. W., Broderick, T. L., & Babu, J. R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/419092 · Cited by 63
Mass spectrometric analysis of protein tyrosine nitration in aging and neurodegenerative diseases
Yeo, W., Kim, Y. J., Kabir, M. H., Kang, J. W., & Kim, K. P. (2015) · Mass Spectrometry Reviews · doi:10.1002/mas.21429 · Cited by 61
Tully, M., & Shi, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020037 · Cited by 61
Shivalingappa, P. C., Jin, H., Anantharam, V., Kanthasamy, A. G., & Kanthasamy, A. (2012) · Parkinson s Disease · doi:10.1155/2012/424285 · Cited by 61
Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasomein vivo
Moszczyńska, A., & Yamamoto, B. K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07147.x · Cited by 60
Bajo‐Grañeras, R., Ganfornina, M. D., Martín-Tejedor, E., & Sánchez, D. (2011) · Glia · doi:10.1002/glia.21200 · Cited by 60
Lee, Y., Kim, Y.-H., Park, S.-J., Huh, J., Kim, S., Kim, S., Kim, J., Jeong, K.-J., Lee, K., Hong, Y., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130776 · Cited by 59
Zaja‐Milatovic, S., Gupta, R. C., Aschner, M., Montine, T. J., & Milatović, D. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.04.009 · Cited by 57
David, M. A., & Tayebi, M. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00251 · Cited by 54
Shin, E., Jeong, J. H., Bing, G., Park, E. S., Chae, J. S., Yen, T. P. H., Kim, W.-K., Wie, M., Jung, B.-D., Kim, H. J., et al. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.11.014 · Cited by 53
Allen, A. T., Maher, K. N., Wani, K. A., Betts, K. E., & Chase, D. L. (2011) · Genetics · doi:10.1534/genetics.111.128512 · Cited by 51
Leelarungrayub, D., Saidee, K., Pothongsunun, P., Pratanaphon, S., Yankai, A., & Bloomer, R. J. (2010) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2010.03.006 · Cited by 50
Zahid, M., SAEED, M. K., Yang, L., Beseler, C. L., Rogan, E. G., & Cavalieri, E. L. (2011) · IUBMB Life · doi:10.1002/iub.538 · Cited by 44
Itzhak, Y., Martin, J. L., & Ali, S. F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19991215)34:4<305::aid-syn6>3.0.co;2-# · Cited by 44
Mohagheghi, F., Khalaj, L., Ahmadiani, A., & Rahmani, B. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9338-3 · Cited by 43
Poly (ADP-Ribose) Polymerase Mediates Diabetes-Induced Retinal Neuropathy
Mohammad, G., Siddiquei, M. M., & El‐Asrar, A. M. A. (2013) · Mediators of Inflammation · doi:10.1155/2013/510451 · Cited by 41
Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide
Madrigal, J. L. M., Moro, M. Á., Lizasoaín, I., Lorenzo, P. L., & Leza, J. C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02467-8 · Cited by 40
He, X., Jittiwat, J., Kim, J.-H., Jenner, A. M., Farooqui, A. A., Patel, S. C., & Ong, W. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.038 · Cited by 38
Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency
Obrosova (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000166 · Cited by 35
Kita, T., Asanuma, M., Miyazaki, I., & Takeshima, M. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13r19cp · Cited by 31
Intrinsic Mechanisms of Poly(ADP-Ribose) Neurotoxicity: Three Hypotheses
Chiarugi, A. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.01.012 · Cited by 31
Dopamine Prevents Nitration of Tyrosine Hydroxylase by Peroxynitrite and Nitrogen Dioxide
Park, S. U., Geddes, T. J., Javitch, J. A., & Kuhn, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304362200 · Cited by 31
Methods for detection and characterization of protein S-nitrosylation
Chen, Y., Ching, W.-C., Lin, Y., & Chen, Y. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.016 · Cited by 30
Oxidative stress is independent of inflammation in the neurodegenerative sanfilippo syndrome type B
Trudel, S., Trécherel, E., Gomila, C., Peltier, M., Aubignat, M., Gubler, B., Morlière, P., Heard, J., & Ausseil, J. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23497 · Cited by 29
Nitro-Oxidative Stress Biomarkers in Active and Inactive Men
Bjork, L., Jenkins, N., Witkowski, S., & Hagberg, J. (2012) · International Journal of Sports Medicine · doi:10.1055/s-0032-1301891 · Cited by 27
Prasad, J. E., Kumar, B., Andreatta, C. P., Nahreini, P., Hanson, A. J., Yan, X. D., & Prasad, K. N. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20058 · Cited by 27
Dopamine Modulates Acetylcholine Release via Octopamine and CREB Signaling in Caenorhabditis elegans
Suo, S., & Ishiura, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072578 · Cited by 25
Meulendyke, K. A., Pletnikov, M. V., Engle, E. L., Tarwater, P. M., Graham, D. R. M., & Zink, M. C. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9332-1 · Cited by 25
Wang, Y.-Q., Bian, G., Bai, Y. M., Cao, R. Y., & Chen, L.-W. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.06.007 · Cited by 24
Hanson, A. J., Prasad, J. E., Nahreini, P., Andreatta, C. P., Kumar, B., Yan, X., & Prasad, K. N. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10726 · Cited by 22
Insulin Regulation of Monoamine Signaling: Pathway to Obesity
Niswender, K. D., Daws, L. C., Avison, M. J., & Galli, A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.167 · Cited by 21
The production of nitrating species by the reaction between nitrite and hypochlorous acid.
Kono, Y. (1995) · PubMed · Cited by 21
Dajas‐Bailador, F., Costa, G., Emmett, S. R., Bonilla, C., & Dajas‐Bailador, F. (1996) · Brain Research · doi:10.1016/0006-8993(96)00133-3 · Cited by 16
Manipulation of microglial activity as a therapy for Alzheimer s disease
Ling, E. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s342 · Cited by 15
Is There a Role for Nitric Oxide in Methamphetamine-Induced Dopamine Terminal Degeneration?
Friend, D. M., Fricks‐Gleason, A. N., & Keefe, K. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9415-2 · Cited by 12
Cited by
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D., Sainz, R. M., Alatorre‐Jimenez, M., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,703
Fricker, M., Tolkovsky, A. M., Borutaite, V., Coleman, M., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,108
Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 700
NADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
Tafani, M., Sansone, L., Limana, F., Arcangeli, T., De Santis, E., Polese, M., Fini, M., & Russo, M. A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3907147 · Cited by 373
Metadata
- Authors
- Cobb, C. A., & Cole, M. P.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 84
- Pages
- 4-21
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W391900960
- Cited by
- 298
- References
- 149
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.